Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 2/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | FLT3 | P36888 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.37 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | DAO | P14920 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | BRD4 | O60885 | 1/20 | 0.37 |
| ▸ | DDO | Q99489 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quinoline SCHEMBL27603533 | 0.86 | ALDH1A1 (0.45) | AOC3ALOX5NPC1RAB9AKDM4E | |
| SCHEMBL6157427 | 0.81 | CYP2A6 (0.44) | AOC3ALOX5LOXL2CYP2A6CA2 | |
| SCHEMBL5049788 | 0.79 | AOC3 (0.50) | AOC3ALOX5LOXL2CYP2A6CA2 | |
| SCHEMBL14532292 | 0.79 | ALOX5 (0.48) | AOC3ALOX5LOXL2CYP2A6CA2 | |
| SCHEMBL6543889 | 0.79 | ALOX5 (0.44) | AOC3ALOX5LOXL2CYP2A6CA2 | |
| SCHEMBL30063329 | 0.79 | ALOX5 (0.44) | AOC3ALOX5LOXL2CYP2A6CA2 | |
| SCHEMBL4382025 | 0.79 | CYP2A6 (0.42) | AOC3ALOX5LOXL2CYP2A6CA2 | |
| SCHEMBL23468379 | 0.76 | ALOX5 (0.51) | AOC3ALOX5LOXL2CYP2A6CA2 | |
| SCHEMBL3229357 | 0.76 | ALOX5 (0.55) | AOC3ALOX5LOXL2CYP2A6CA2 | |
| SCHEMBL4760638 | 0.75 | ALOX5 (0.41) | AOC3ALOX5LOXL2CYP2A6CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 180 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117899209-A | Vaccination and antibody production platform | 德国癌症研究公共权益基金会 | 2024-04-19 | — | — | CN | claimed |
| WO-2023150396-A1 | DEVICES, METHODS AND KITS FOR DETECTING EXPLOSIVES AND ILLICIT DRUG SUBSTANCES | TRACE EYE-D, LLC (US) | 2023-08-10 | — | — | WO | claimed |
| CN-108853509-A | The treatment and pharmaceutical composition of depression | 浙江大学 | 2018-11-23 | — | — | CN | claimed |
| CN-101489548-A | Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia | NEUROKEY AS (DK) | 2009-07-22 | — | — | CN | claimed |
| CN-1867332-A | Comprising a selective CB1Combination therapy of obesity with antagonists and lipase inhibitors | SOLVAY PHARM GMBH (DE) | 2006-11-22 | — | — | CN | claimed |
| CN-1845735-A | Novel medical use of selective cb1-receptor antagonists | SOLVAY PHARM GMBH (DE) | 2006-10-11 | — | — | CN | claimed |
| CN-1610542-A | New use for the treatment of gastroesophageal reflux disease | ASTRAZENECA AB (SE) | 2005-04-27 | — | — | CN | claimed |
| WO-2024108201-A2 | CANNABIGEROLIC ACID (CBGA) AND CANNABIGEROL (CBG) DERIVED PRODUCTS AND METHODS OF USE | Bazelet Health Systems, Inc. (US) | 2024-05-23 | — | — | WO | disclosed |
| CN-113710235-B | Oral cannabinoid tablet | 诺狄更斯公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117677383-A | Combinations of ketone bodies or ketone-forming compounds, analgesics or antioxidants | 瑞士凯托股份公司 | 2024-03-08 | — | — | CN | disclosed |
| US-20230330115-A1 | COMPOSITION COMPRISING COMBINATIONS OF CANNABINOID HOMOLOGUES THCB (TETRAHYDROCANNABUTOL) AND THCP (TETRAHYDROCANNABIPHOROL) | Green Sky Creations, LLC (US) | 2023-10-19 | — | — | US | disclosed |
| CN-113329743-B | Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizer | 诺狄更斯公司 | 2023-09-05 | — | — | CN | disclosed |
| WO-2023150396-A1 | DEVICES, METHODS AND KITS FOR DETECTING EXPLOSIVES AND ILLICIT DRUG SUBSTANCES | TRACE EYE-D, LLC (US) | 2023-08-10 | — | — | WO | disclosed |
| EP-0348341-A2 | Aminoalkyl indoles, process for their preparation and pharmaceutical compositions thereof | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-12-27 | — | — | EP | disclosed |
| US-4839377-A | TREATMENT OF MIGRAINE | GLAXO GROUP LIMITED (GB) | 1989-06-13 | — | — | US | disclosed |
| EP-0252404-A2 | 5-Hydroxy-3-indoleacetic acid fluorescence polarization immunoassay | ABBOTT LABORATORIES (US) | 1988-01-13 | — | — | EP | disclosed |
| US-4672067-A | 5-substituted 3-aminoalkyl indoles useful in treatment of migraine | GLAXO GROUP LIMITED (GB) | 1987-06-09 | — | — | US | disclosed |
| US-4636521-A | ANALGESICS | GLAXO GROUP LIMITED (GB) | 1987-01-13 | — | — | US | disclosed |
| US-4636521-A | ANALGESICS | GLAXO GROUP LIMITED (GB) | 1987-01-13 | — | — | US | disclosed |
| US-4374846-A | N-Amino alkyl indole compounds compositions containing same, and a method of using same in therapy of disorders of gastrointestinal motility | KALI-CHEMIE PHARMA GMBH (DE) | 1983-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230330115-A1 | COMPOSITION COMPRISING COMBINATIONS OF CANNABINOID HOMOLOGUES THCB (TETRAHYDROCANNABUTOL) AND THCP (TETRAHYDROCANNABIPHOROL) | CNR2, CNR1, FAAH | AOC3 3303/4885ALOX5 1204/4885LOXL2 2504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.